Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Cancer is a leading cause of death worldwide, and among all cancers, colorectal cancer ranks second in mortality, responsible ...

The CRISPR-Cas9 gene-editing tool is as much in the spotlight as it is under scrutiny. Researchers are eager to make genetic modifications to DNA across ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

For years Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their sights - trying to capture the ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

The Functional Genomics Screening Laboratory, based at the Milner Therapeutics Institute, has won an OBN Award in the ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...

In research published today in Nucleic Acid Research, co-first author Seong Guk Park, PhD, and corresponding author Elizabeth Kellogg, PhD, St. Jude Department of Structural Biology, designed a ...